INTRODUCTION
Zymosan (yeast cell walls) induces an acute inflammatory response in the skin and peritoneal cavity of rabbits [1] [2] [3] . This response is characterized by local microvascular plasma protein leakage and the accumulation of neutrophil leucocytes. The peak rate of plasma protein leakage occurs within 2 h of zymosan injection and is dependent on the presence of circulating neutrophils. The early response is largely due to the extravascular generation of the complement fragment C5a, which induces a rapid adherence of circulating neutrophils to microvascular endothelial cells, followed by neutrophil emigration [1, 4, 5] . The interaction between neutrophils and endothelial cells gives rise to increased microvascular permeability to plasma proteins [4] .
We have recently obtained evidence that another neutrophil chemoattractant is generated later than CSa, i.e. at 4-6 h after intraperitoneal injection of zymosan (P. D. Collins, P. J. Jose & T. J. Williams, unpublished work). Vascular-permeabilityincreasing activity and neutrophil chemoattractant activity in fluids obtained up to 2 h after intraperitoneal injection of zymosan were abolished by anti-CSa antibodies. However, 4-6 h exudate fluids contained substantial activity, even in the presence of an excess of anti-CSa antibodies, indicating the presence of a neutrophil chemoattractant, or chemoattractants, other than C5a.
The present paper describes the purification and N-terminal amino-acid-sequence analysis of this novel activity generated in vivo. The purified peptide shows substantial similarity to human interleukin 8 (IL-8), sufficient for it to be considered a rabbit homologue. IL-8 is the name proposed for a cytokine relea8ed in vitro from a variety of cell types, primarily cells of the monocyte/macrophage lineage, and previously known by a variety of other names which describe its ability to activate neutrophils in vitro [6] [7] [8] [9] [10] [11] [12] . Human IL-8 induces neutrophil accumulation and neutrophil-dependent oedema formation in the rabbit [13] [14] [15] .
The present paper provides evidence that IL-8 is generated in vivo in an inflammatory reaction characterized by an early phase of extravascular complement activation. Thus these observations suggest that IL-8 could provide a link between the early and later phases of the inflammatory response.
MATERIALS AND METHODS Collection of inflammatory exudates
New Zealand White rabbits (3-5 kg; Froxfield Farm, Froxfield, Hants., U.K.) were anaesthetized with intravenous sodium pentobarbitone (30 mg/kg), and a suspension of zymosan [500 mg in 75 ml of sterile saline (0.9 % NaCl)] was injected into the peritoneal cavity via a 16-gauge polyethylene cannula [3] .
Polymixin B sulphate (40 #M) was mixed with the zymosan to inhibit the effects of any endotoxin present. After 6 h the animals were killed by an anaesthetic overdose and an incision was made (10 cm) through the ventral surface of the abdomen into the peritoneal cavity. All the available exudate was collected into heparin (10 units/ml), kept cold on ice, and 50 ml of sterile saline was added to wash out the remaining exudate. Samples were centrifuged (2000 g for 10 Rabbit skin bioassay for mediators of oedema fonnation and neutrophil accumulation Inflammatory activity in the peritoneal exudate, at various stages in the purification, was monitored by its ability to induce oedema formation [16] and neutrophil accumulation (17, 18] in rabbit skin. Briefly, rabbits were anaesthetized with sodium pentobarbitone, the dorsal skin was shaved and radiolabelled tracers (1251-albumin and, in some experiments, "'In-neutrophils) were injected intravenously. Test samples, mixed with a potentiating dose of prostaglandin E2 (3 x 10-10 mol/100 #1 per skin site) to fa-cilitate measurement [16] and goat anti-(rabbit C5a) IgG to block responses to any remaining C5a [19] , were injected intradermally in triplicate. After 30 min the animals were killed with an anaesthetic overdose. The dorsal skin was removed, and the injection sites were punched out a9'counted for radioactivity in a multi-well Cobra Auto-Gamma radiation counter with spill-over correction (Packard) .
Aliquots of h.p.l.c. fractions used for bioassay (2-10 % of each column fraction) were freeze-dried in the presence of a freezing mixture designed to prevent absorption of biological activity to the tubes; when reconstituted with water, each sample contained 0.1 % BSA in PBS, pH 7.4. Results (mean+ S.E.M.) are expressed as,ul ofplasma/skin site (oedema formation) and "'In-neutrophil accumulation/skin site.
Removal of C5a using an affinity gel
Guinea-pig anti-(rabbit C5a) antiserum [2] was mixed with an equal volume of Protein A-Sepharose 6BCL at pH 8.0. After washing off unbound material, the bound IgG was covalently attached by use ofthe homobifunctional agent dimethyl pimelimidate [20] . Peritoneal exudate fluid, prepared as above, was mixed with the anti-C5a gel (15 ml of exudate/ml of gel) for 30 min at room temperature and then centrifuged (370 g for 5 min). The supernatant plus a saline wash of the gel was used in subsequent purification steps. By using this procedure, the C5a content of the exudate was reduced from 48.0 to 0.3 nm, as determined by radioimmunoassay [2] . The anti-CSa gel was regenerated for further use by washing with 0.2 M-glycine/HCl buffer, pH 2.5, followed by PBS, pH 7.4.
Cation exchange
The CSa-depleted exudate was adjusted to pH 5.5 using 0.15 M-HCI and mixed with CM-Sephadex C25 (50 ml of exudate/ml of gel, equilibrated in PBS, pH 5.5) for 30 min. The gel was allowed to settle overnight at 4 'C. Most proteins (> 90 %) remained in the supernatant, which had no detectable activity in the rabbit skin oedema assay. After a wash step with PBS, pH 5.5, the active material was eluted with 1.5 M-NaCl in 0.075 M-disodium phosphate (pH 8.2, 4 ml/ml of gel). The eluate was diluted 10- fold with water and the pH adjusted to 5.5 with 0.15 M-HCI. This was filtered through a 0.2 ,tm-pore-size filter and applied to a TSK 535CM h.p.l.c. column (0.75 cm x 15 cm, equilibrated in pH 5.5 PBS) at a flow rate of 1 ml/min. The column was washed at 1 ml/min with pH 5.5 PBS (10 min) and then with 0.1 Mammonium acetate buffer, pH 5.5 (10 min). No bioactive material was detected in the breakthrough or washes. The column was eluted with a linear gradient of 0.1 M-ammonium acetate, pH 5.5, to 1.0 M-ammonium acetate, pH 7.6 (0.5 ml/min; 36 min). This was followed by a steeper gradient of 1.0-2.0 M-ammonium acetate, pH 7.6. Fractions were collected every 2 min.
Size exclusion
Freeze-dried active material from the cation-exchange h.p.l.c. column was dissolved in 800,1 of 0.1 % trifluoroacetic acid (TFA) and-applied (two runs of 400 1d) to a TSK G2000SW h.p.l.c. column (0.75 cm x 60 cm; equilibrated in 0.1 % TFA). This was eluted at 0.8 ml/min, and 1 min fractions were collected.
Reversed phase h.p.l.c.
Freeze-dried active material from the size-exclusion-h.p.l.c. step was subjected to repeated chromatography on a wide-pore [30 nm (300 A)] Vydac C18 column (0.4 cm x 25 cm). Three different gradients of acetonitrile in 0.1 % TFA were run, each at 0.5 ml/min, with 1 min fractions being collected. The optimal gradient, used on the third run, was determined to be from 30 to 50 % acetonitrile over 30 min.
PAGE analysis
Aliquots from all the active fractions were put aside during the course of the purification and analysed by PAGE after the reversed-phase fractionation. The Phast gel system used for this procedure consisted of SDS-containing precast gels (8-25o% acrylamide gradient) in conjunction with SDS buffer strips. 
Amino acid sequencing
The N-terminal sequence was obtained by using an Applied Biosystems model 477A pulse-liquid sequencer with an on-line amino acid phenylthiohydantoin derivative analyser (model 120A, utilizing fast cycle chemistry) [21] . Half the material in fraction 39 from the final reversed-phase h.p.l.c. step was used for sequencing and, because this amount of protein was limiting, no chemical modification of putative cysteine residues was performed before Edman degradation. The N-terminal alanine signal of 40 pmol (background subtracted) suggested a sequencer loading of approx. 60-70 pmol of the protein (typical first-step yield, 60 %). 
RESULTS
Purification Inflammatory exudate obtained 6 h after the intraperitoneal injection of zymosan was depleted of C5a by use of an affinity gel. The remaining neutrophil chemoattractant and oedemaforming activity was found to bind to the cation-exchanger, CMSephadex, at pH 5.0 and 5.5, but not at pH 6.0 and above (at an iso-osmotic salt concentration; results not shown). The cationexchange step at pH 5.5 facilitated the subsequent h.p.l.c. steps by removing a substantial (> 90 %) amount of protein. The cation-exchange h.p.l.c. step produced a broad peak ofbioactivity (Fig. 1) .
The active fractions from the ion-exchange step were pooled, freeze-dried and subjected to the size-exclusion h.p.l.c. step in 0.1 % TFA. A single peak of oedema-forming activity, corresponding to approx. 9 kDa, was observed (Fig. 2) .
Active fractions from the sizing step were pooled and freeze- again pooled and freeze-dried for application to the third and final reversed-phase step, which incorporated a gradient of 30-50 % acetonitrile over 30 min. These conditions separated two peaks of activity in both the oedema-forming and the neutrophil accumulation assays (Fig. 3) .
PAGE analysis
The extent of purification was monitored by SDS/PAGE, using 8-25 % gels under reducing conditions, followed by silver staining. Analysis of individual fractions from the last C18 purification step (Fig. 4) revealed a single band of 6-8 kDa in fractions 39 and 40, corresponding to a protein slightly larger than the hrMDNCF/IL-8 standard. Fraction 34, which was a discrete peak of bioactivity, had at least three bands, none of which corresponded to the hrMDNCF/IL-8 standard.
Sequencing
On the evidence of PAGE and bioassay analysis, fraction 39 from the final reversed-phase step was subjected to N-terminal amino-acid-sequence analysis. Only one sequence was detected, and sequencing proceeded to residue 31, with three of these residues remaining unidentified [ Fig; 5 ; rabbit peritoneal factor (RPF)]. Sequence simitarity with a family ofneutrophil-activating human cytokines (now known as IL-8) is also given in Fig. 5 . 
DISCUSSION
The present paper describes the generation in vivo, purification and N-terminal characterization of a rabbit neutrophil chemoattractant and oedema-inducing protein that shows 75 % sequence identity with human IL-8. Recently human IL-8 has been shown to stimulate neutrophil accumulation and oedema formation in the rabbit [13] [14] [15] . A characteristic shared by IL-8 and related sequences is the conservation of two disulphide bonds [22, 23] . These are formed from a pair of cysteine residues consistently positioned near the N-terminus which both link to cysteine positions in the latter half of the molecule. [24] [25] [26] [27] . However, as Fig. 5 shows, this AVLPR pentapeptide is found in human IL-8 released after stimulation of lymphocytes [28] and endothelial cells [29] . AVLPR is also found in a very similar chemotactic protein (LUCT) which is released constitutively by a human lung giant-cell-carcinoma cell line [30] .
The present study has identified a protein of the IL-8 family in an 'in vivo' model of inflammation. Factors with neutrophil chemoattractant properties in vivo have been detected in endotoxin-induced inflammatory exudates generated in the rat peritoneal and rabbit pleural cavities [31, 32] . The rabbit factor is unlikely to be IL-8, since it was devoid of chemotactic activity in vitro and had a molecular mass of 45 kDa [32] . Although the rat factor was not purified, its activities in vivo and in vitro [31] resemble that of IL-8. We used polymixin B sulphate to negate the effects of any endotoxin contamination of the inflammatory stimulus. Thus we conclude that the IL-8 generation in our experiments was in response to the zymosan particles, perhaps after opsonization, rather than to endotoxin.
It will be important to identify which cells are responsible for the release of the rabbit peritoneal factor. IL-8 production, or the expression of mRNA, has been demonstrated in vitro in stimulated monocytes, macrophages, lymphocytes, endothelial cells and fibroblasts. The work of Cunha & Ferreira [31] in the rat suggests that tissue macrophages were the source of their peritoneal neutrophil chemoattractant. However, the presence of the AVLTR pentapeptide at the N-terminus of the rabbit peritoneal factor suggests that the source might be cells other than the macrophage, since, in man, lymphocytes [28] and endothelial cells [29] , but apparently not macrophages [24] , secrete IL-8 containing a similar pentapeptide (AVLPR) at the N-terminus.
The purification and identification of a rabbit homologue of IL-8 generated in vivo provides the basis for further investigations of the generation, action and cellular source of IL-8 in inflammatory reactions.
